Literature DB >> 35188696

A curious case of cyclin-dependent kinases in neutrophils.

Ramizah Syahirah1, Alan Y Hsu1,2,3, Qing Deng1,4,5.   

Abstract

Neutrophils are terminally differentiated, short-lived white blood cells critical for innate immunity. Although cyclin-dependent kinases (CDKs) are typically related to cell cycle progression, increasing evidence has shown that they regulate essential functions of neutrophils. This review highlights the roles of CDKs and their partners, cyclins, in neutrophils, outside of cell cycle regulation. CDK1-10 and several cyclins are expressed in neutrophils, albeit at different levels. Observed phenotypes associated with specific inhibition or genetic loss of CDK2 indicate its role in modulating neutrophil migration. CDK4 and 6 regulate neutrophil extracellular traps (NETs) formation, while CDK5 regulates neutrophil degranulation. CDK7 and 9 are critical in neutrophil apoptosis, contributing to inflammation resolution. In addition to the CDKs that regulate mature neutrophil functions, cyclins are essential in hematopoiesis and granulopoiesis. The pivotal roles of CDKs in neutrophils present an untapped potential in targeting CDKs for treating neutrophil-dominant inflammatory diseases and understanding the regulation of the neutrophil life cycle. ©2022 Society for Leukocyte Biology.

Entities:  

Keywords:  CDK2; HL-60 cells; granulopoiesis; innate immunity; neutrophil activation

Mesh:

Substances:

Year:  2022        PMID: 35188696      PMCID: PMC9035055          DOI: 10.1002/JLB.2RU1021-573R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   6.011


  138 in total

1.  Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb.

Authors:  B Driscoll; A T'Ang; Y H Hu; C L Yan; Y Fu; Y Luo; K J Wu; S Wen; X H Shi; L Barsky; K Weinberg; A L Murphree; Y K Fung
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

Review 2.  Cyclins, cyclin-dependent kinases and differentiation.

Authors:  C Y Gao; P S Zelenka
Journal:  Bioessays       Date:  1997-04       Impact factor: 4.345

Review 3.  Neutrophil-Based Drug Delivery Systems.

Authors:  Dafeng Chu; Xinyue Dong; Xutong Shi; Canyang Zhang; Zhenjia Wang
Journal:  Adv Mater       Date:  2018-03-26       Impact factor: 30.849

4.  Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis.

Authors:  Richard B Moss; Sunil J Mistry; Michael W Konstan; Joseph M Pilewski; Eitan Kerem; Ruth Tal-Singer; Aili L Lazaar
Journal:  J Cyst Fibros       Date:  2012-09-17       Impact factor: 5.482

5.  Neutrophils scan for activated platelets to initiate inflammation.

Authors:  Vinatha Sreeramkumar; José M Adrover; Ivan Ballesteros; Maria Isabel Cuartero; Jan Rossaint; Izaskun Bilbao; Maria Nácher; Christophe Pitaval; Irena Radovanovic; Yoshinori Fukui; Rodger P McEver; Marie-Dominique Filippi; Ignacio Lizasoain; Jesús Ruiz-Cabello; Alexander Zarbock; María A Moro; Andrés Hidalgo
Journal:  Science       Date:  2014-12-04       Impact factor: 47.728

Review 6.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

Review 7.  Cellular control of gene expression by T-type cyclin/CDK9 complexes.

Authors:  Judit Garriga; Xavier Graña
Journal:  Gene       Date:  2004-08-04       Impact factor: 3.688

8.  Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation.

Authors:  A E Leitch; C D Lucas; J A Marwick; R Duffin; C Haslett; A G Rossi
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

9.  A novel function for Cyclin A2: control of cell invasion via RhoA signaling.

Authors:  Nikola Arsic; Nawal Bendris; Marion Peter; Christina Begon-Pescia; Cosette Rebouissou; Gilles Gadéa; Nathalie Bouquier; Frédéric Bibeau; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  J Cell Biol       Date:  2012-01-09       Impact factor: 10.539

10.  Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo.

Authors:  Laura J Hoodless; Christopher D Lucas; Rodger Duffin; Martin A Denvir; Christopher Haslett; Carl S Tucker; Adriano G Rossi
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

View more
  1 in total

1.  miR-30d Inhibition Protects IPEC-J2 Cells Against Clostridium perfringens Beta2 Toxin-Induced Inflammatory Injury.

Authors:  Kaihui Xie; Qiaoli Yang; Zunqiang Yan; Xiaoli Gao; Xiaoyu Huang; Pengfei Wang; Juanli Zhang; Jiaojiao Yang; Jie Li; Shuangbao Gun
Journal:  Front Vet Sci       Date:  2022-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.